Literature DB >> 25776839

An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial.

Habibollah Esmaily1, Amirhossein Sahebkar, Mehrdad Iranshahi, Shiva Ganjali, Akram Mohammadi, Gordon Ferns, Majid Ghayour-Mobarhan.   

Abstract

OBJECTIVE: To investigate the effectiveness of curcumin, a natural polyphenolic compound with antioxidant and anti-inflammatory activities, on the frequency of symptoms of anxiety and depression in obese individuals.
METHODS: In this double blind, cross-over trial, 30 obese subjects were randomized to receive either curcumin (1 g/day) or placebo for a period of 30 days. Following a wash-out interval of 2 weeks, each subject was crossed over to the alternative regimen for a further 30 days. Severity of anxiety and depression was assessed at baseline and at weeks 4, 6 and 10 of the trial using the Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) scales, respectively.
RESULTS: Mean BAI score was found to be significantly reduced following curcumin therapy (P=0.03). However, curcumin supplementation did not exert any significant impact on BDI scores (P=0.7).
CONCLUSION: Curcumin has a potential anti-anxiety effect in individuals with obesity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25776839     DOI: 10.1007/s11655-015-2160-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  39 in total

1.  Aging: a theory based on free radical and radiation chemistry.

Authors:  D HARMAN
Journal:  J Gerontol       Date:  1956-07

2.  Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia.

Authors:  P Kuppusamy; S T Ohnishi; Y Numagami; T Ohnishi; J L Zweier
Journal:  J Cereb Blood Flow Metab       Date:  1995-11       Impact factor: 6.200

3.  The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression.

Authors:  Arianne K B van Reedt Dortland; Sophie A Vreeburg; Erik J Giltay; Carmilla M M Licht; Nicole Vogelzangs; Tineke van Veen; Eco J C de Geus; Brenda W J H Penninx; Frans G Zitman
Journal:  Psychoneuroendocrinology       Date:  2012-06-18       Impact factor: 4.905

4.  Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.

Authors:  Yunes Panahi; Amirhossein Sahebkar; Mojtaba Amiri; Seyyed Masoud Davoudi; Fatemeh Beiraghdar; Seyyedeh Leila Hoseininejad; Marjan Kolivand
Journal:  Br J Nutr       Date:  2011-11-18       Impact factor: 3.718

5.  GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice.

Authors:  Neeraj Gilhotra; Dinesh Dhingra
Journal:  Brain Res       Date:  2010-07-12       Impact factor: 3.252

Review 6.  Recent advances in pharmacotherapy for hypertriglyceridemia.

Authors:  Amirhossein Sahebkar; Gerard T Chew; Gerald F Watts
Journal:  Prog Lipid Res       Date:  2014-07-30       Impact factor: 16.195

7.  Associations between anxiety, depression, and the metabolic syndrome.

Authors:  Michael R Skilton; Philippe Moulin; Jean-Louis Terra; Fabrice Bonnet
Journal:  Biol Psychiatry       Date:  2007-06-05       Impact factor: 13.382

Review 8.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

Review 9.  Pindolol augmentation of antidepressant response.

Authors:  Francesc Artigas; Albert Adell; Pau Celada
Journal:  Curr Drug Targets       Date:  2006-02       Impact factor: 3.465

Review 10.  Potentials of curcumin as an antidepressant.

Authors:  Shrinivas Kulkarni; Ashish Dhir; Kiran Kumar Akula
Journal:  ScientificWorldJournal       Date:  2009-11-01
View more
  34 in total

Review 1.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

2.  Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial.

Authors:  Yunes Panahi; Nahid Khalili; Ebrahim Sahebi; Soha Namazi; Maryam Saberi Karimian; Muhammed Majeed; Amirhossein Sahebkar
Journal:  Inflammopharmacology       Date:  2016-12-07       Impact factor: 4.473

Review 3.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

Review 4.  Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Kowsar Bavarsad; George E Barreto; Mousa-Al-Reza Hadjzadeh; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-06-09       Impact factor: 5.590

5.  A Realistic View on "The Essential Medicinal Chemistry of Curcumin".

Authors:  Fatemeh Bahadori; Mutlu Demiray
Journal:  ACS Med Chem Lett       Date:  2017-09-14       Impact factor: 4.345

6.  Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study.

Authors:  Buranee Kanchanatawan; Sookjaroen Tangwongchai; Atapol Sughondhabhirom; Siriluck Suppapitiporn; Solaphat Hemrunrojn; André F Carvalho; Michael Maes
Journal:  Neurotox Res       Date:  2018-01-11       Impact factor: 3.911

Review 7.  Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinical Data.

Authors:  Mohammad Amin Khodadadegan; Shakiba Azami; Paul C Guest; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  The Effect of Curcumin Supplemsentation on Anthropometric Indices in Overweight and Obese Individuals: A Systematic Review of Randomized Controlled Trials.

Authors:  Zahra Safari; Mohammad Bagherniya; Gholamreza Askari; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Curcumin: A Review of Its Effects on Epilepsy.

Authors:  Fatemeh Forouzanfar; Muhammed Majeed; Tannaz Jamialahmadi; Amirhosein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Zebrafish as an alternative method for determining the embryo toxicity of plant products: a systematic review.

Authors:  Maria Alice Pimentel Falcão; Lucas Santos de Souza; Silvio Santana Dolabella; Adriana Gibara Guimarães; Cristiani Isabel Banderó Walker
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-24       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.